BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16

• Press Releases

  CoRegen, Inc. Receives FDA Clearance to Advance CRG-150 into Phase 1/2a Clinical Trials, Pioneering a New Frontier in Cell Therapy for Multiple Solid Tumor Types

  July 7, 2026

   · 

  4 min read
• Press Releases

  Arnatar Therapeutics Receives China NMPA Clearance to Initiate First-in-Human Study of ART5, a First-in-Class Up-Regulating ASO Designed to Restore Polycystin-1 for the Treatment of ADPKD

  July 7, 2026

   · 

  4 min read
• Press Releases

  Theriva™ Biologics Announces Regulatory Authorization to Proceed with a VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma

  July 7, 2026

   · 

  10 min read
• Press Releases

  Independent University of Lille Study Shows Rose Bengal Sodium Produces Opposing Mechanistic Effects at the Same Dose

  July 7, 2026

   · 

  8 min read
• Press Releases

  Ethos Laboratories Announces Exclusive U.S. Launch of CNSDose™, Following Successful MolDX® Technical Assessment

  July 7, 2026

   · 

  5 min read
• Press Releases

  Praxis Precision Medicines and Remagine Labs Announce Strategic Collaboration to Develop Transdermal Ulixacaltamide for Essential Tremor

  July 7, 2026

   · 

  5 min read
• Press Releases

  Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration

  July 7, 2026

   · 

  9 min read
• Press Releases

  Correction: Biovica appoints Maria Ekdahl as new Chief Financial Officer

  July 7, 2026

   · 

  3 min read
• Press Releases

  enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial

  July 7, 2026

   · 

  4 min read
• Press Releases

  Absentia Labs’ Digital Liver Model Becomes First AI Drug Development Tool Accepted Into FDA Qualification Program

  July 7, 2026

   · 

  4 min read